| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUUGUGAUUCACUGCUAAGGAUCUUAAGCCCACCUUGGCCCUGACCUCG… | 1175 nt | 0.6272 | |
| GGGACGCACUCCGGAGCGCACUGCGUGGUCGCACCCUACCCGGGCUGCC… | 847 nt | 0.6222 | |
| GGGACGCACUCCGGAGCGCACUGCGUGGUCGCACCCUACCCGGGCUGCC… | 827 nt | 0.6215 | |
| GGGACGCACUCCGGAGCGCACUGCGUGGUCGCACCCUACCCGGGCUGCC… | 812 nt | 0.6232 | |
| CUUGUGAUUCACUGCUAAGGAUCUUAAGCCCACCUUGGCCCUGACCUCG… | 1160 nt | 0.6284 |
Enables ribosylnicotinamide kinase activity and ribosylnicotinate kinase activity. Predicted to be involved in NAD metabolic process. Predicted to act upstream of or within negative regulation of myoblast differentiation. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
A study in humans developed a 17-plex mRNA assay for forensic organ tissue identification, where the NMRK2 was included as a general muscle marker for identifying both skeletal and heart muscle [Lindenbergh et al. DOI:10.1007/s00414-013-0895-7]. This assay demonstrated high specificity and sensitivity, successfully analyzing a blind test set of 20 specimens including mixtures and mock stabbing samples, with the NMRK2 contributing to the correct inference of muscle tissues. A study in humans demonstrated that the NMRK2 is a marker used in targeted massively parallel sequencing assays for heart muscle tissue identification [Haas et al. DOI:10.1016/j.fsigen.2021.102486]. This integrative review further notes that the NMRK2 is an mRNA marker for heart tissue identification, specifically for cause of death analysis [Lei et al. DOI:10.1093/gpbjnl/qzag007].